Blog

Nov 8, 2024, 18:44

Mamtha Balla: Tackling TIL therapy challenges in COVID-19

Mamtha Balla, Transplant Oncology-ID fellow at MD Anderson Cancer Center, shared a post on X:

”I am excited to present our Supriya Peshin poster on Tackling TIL therapy challenges in COVID-19 patients at the IOTOX symposium in Houston MD Anderson Cancer Center, Texas!

I’m thrilled to express my gratitude to IOTOX for allowing me to spotlight an incredibly significant topic—TIL, which has just received approval for solid cancers in February 2024!

It’s vital to grasp the distinctions between CART and TIL, and we must also navigate patient care for those with COVID-19 amidst these advancements. The possibilities in this field are fascinating!

Thanks to my mentors Pablo Okhuysen and Javier Adachi, Roy Chemaly for supporting me!”

cancer CART COVID-19 H.O.M.E Hem-Onc Fellows Network Houston IMG Oncologists IOTOX symposium IOTOX2024 Javier Adachi Mamtha Balla MD Anderson Cancer Center OncoDaily Oncology Pablo Okhuysen Roy Chemaly SITC 2024 Supriya Peshin Texas TIL TIL Therapy UTHealth Houston Infectious Diseases Women in Oncology

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage